Literature DB >> 27596073

Guidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.

Yazan Haddad1,2, Zbynek Heger1,2, Vojtech Adam1,2.   

Abstract

The human dopamine, norepinephrine, and serotonin transporters (hDAT, hNET, and hSERT) are carriers of neurotransmitters and targets for many drugs. Pioneering works in the past three years to elucidate experimental models of the Drosophila dDAT and human hSERT structures will rapidly impact the field of neuroscience. Here, we evaluated automated homology-based human models of these transporters, employing systematic physics-based, knowledge-based, and empirical-based check. Modeling guidelines were conveyed with attention to the central binding site (S1), secondary binding site (S2), and the extracellular loops EL2 and EL4. Application of new experimental models (dDAT and hSERT) will improve the accuracy of homology models, previously utilizing prokaryotic leucine transporter (LeuT) structure, and provide better predictions of ligand interactions, which is required for understanding of cellular mechanisms and for development of novel therapeutics.

Entities:  

Keywords:  Homology-based; dopamine transporter; norepinephrine transporter; protein structure; serotonin transporter; template-based

Mesh:

Substances:

Year:  2016        PMID: 27596073     DOI: 10.1021/acschemneuro.6b00242

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  9 in total

1.  Non-conserved residues dictate dopamine transporter selectivity for the potent synthetic cathinone and psychostimulant MDPV.

Authors:  Tyler W E Steele; Zachary Spires; Charles B Jones; Richard A Glennon; Małgorzata Dukat; Jose M Eltit
Journal:  Neuropharmacology       Date:  2021-10-04       Impact factor: 5.250

2.  Targeting Neuroblastoma Cell Surface Proteins: Recommendations for Homology Modeling of hNET, ALK, and TrkB.

Authors:  Yazan Haddad; Zbyněk Heger; Vojtech Adam
Journal:  Front Mol Neurosci       Date:  2017-01-20       Impact factor: 5.639

3.  Spectrum-Effect Relationships Between the Bioactive Ingredient of Syringa oblata Lindl. Leaves and Its Role in Inhibiting the Biofilm Formation of Streptococcus suis.

Authors:  Yan-Yan Liu; Xing-Ru Chen; Ling-Fei Gao; Mo Chen; Wen-Qiang Cui; Wen-Ya Ding; Xue-Ying Chen; Bello-Onaghise God'spower; Yan-Hua Li
Journal:  Front Pharmacol       Date:  2018-06-05       Impact factor: 5.810

4.  Norepinephrine transporter-derived homing peptides enable rapid endocytosis of drug delivery nanovehicles into neuroblastoma cells.

Authors:  Yazan Haddad; Marketa Charousova; Hana Zivotska; Zbynek Splichal; Miguel Angel Merlos Rodrigo; Hana Michalkova; Sona Krizkova; Barbora Tesarova; Lukas Richtera; Petr Vitek; Kamila Stokowa-Soltys; David Hynek; Vedran Milosavljevic; Simona Rex; Zbynek Heger
Journal:  J Nanobiotechnology       Date:  2020-07-13       Impact factor: 10.435

5.  3D similarities between the binding sites of monoaminergic target proteins.

Authors:  Gabriel Núñez-Vivanco; Angélica Fierro; Pablo Moya; Patricio Iturriaga-Vásquez; Miguel Reyes-Parada
Journal:  PLoS One       Date:  2018-07-20       Impact factor: 3.240

6.  Structure Modeling of the Norepinephrine Transporter.

Authors:  Izabella Góral; Kamil Łątka; Marek Bajda
Journal:  Biomolecules       Date:  2020-01-07

7.  Assessment of Paroxetine Molecular Interactions with Selected Monoamine and γ-Aminobutyric Acid Transporters.

Authors:  Magdalena Kowalska; Łukasz Fijałkowski; Alicja Nowaczyk
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

8.  Ten quick tips for homology modeling of high-resolution protein 3D structures.

Authors:  Yazan Haddad; Vojtech Adam; Zbynek Heger
Journal:  PLoS Comput Biol       Date:  2020-04-02       Impact factor: 4.475

9.  Structure-Function of the High Affinity Substrate Binding Site (S1) of Human Norepinephrine Transporter.

Authors:  Prerna Jha; Lotten Ragnarsson; Richard J Lewis
Journal:  Front Pharmacol       Date:  2020-03-05       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.